计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
,适用于对基线干扰要求严格的色谱和分析工作流程。
2-8°C储存,干燥。低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Grazoprevir potassium salt (MK-5172 potassium salt) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with K i s of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively Grazoprevir potassium salt inhibits SARS-CoV-2 3CL pro activity
In Vitro
In biochemical assays, Grazoprevir (MK-5172) is effective against a panel of major genotypes and variants engineered with common resistant mutations, with K i of 0.01±<0.01 nM (gt1b), 0.01±0.01 nM (gt1a), 0.08±0.02 nM (gt2a), 0.15±0.06 nM (gt2b), 0.90±0.2 nM (gt3a), 0.07±0.01 nM (gt1b R155K ), 0.14±0.03 nM (gt1b D168V ), 0.30±0.04 nM (gt1b D168Y ), 5.3±0.9 nM (gt1b A156T ), and 12±2 nM (gt1b A156V ), respectively. In the replicon assay, Grazoprevir demonstrates subnanomolar to low-nanomolar EC 50 s against genotypes 1a, 1b, and 2a, with EC 50 s of 0.5±0.1 nM, 2±1 nM, and 2±1 nM for gt1b con1 , gt1a, and gt2a, respectively. Grazoprevir is potent against a panel of HCV replication mutants NS5A (Y93H) (EC 50 =0.7±0.3 nM), NS5B nucleosides (S282T) (EC 50 =0.3±0.1 nM), and NS5B (C316Y) (EC 50 =0.4±0.2). Grazoprevir (MK-5172) maintains the excellent potency against the gt 3a enzyme as well as a broad panel of mutant enzymes, has excellent potency in the replicon system [gt1b IC 50 (50% NHS)=7.4 nM; gt1a IC 50 (40% NHS)=7 nM], and shows excellent rat liver exposure. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Grazoprevir (MK-5172) demonstrates efficacy in vivo against chronic-HCV-infected chimpanzees . When dosed to dogs, Grazoprevir (MK-5172) shows low clearance of 5 mL/min/kg and a 3 h half-life after iv dosing and has good plasma exposure (AUC=0.4 μM h) after a 1 mg/kg oral dose. Dog liver biopsy studies showed that the liver concentration of Grazoprevir after the 1 mg/kg oral dose is 1.4 μM at the 24 h time point. Similar to its behavior in rats, Grazoprevir demonstrates effective partitioning into liver tissue and maintains high liver concentration, relative to potency, 24 h after oral dosing in dogs. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:Ki: 0.01±<0.01 nM (gt1b), 0.01±0.01 nM (gt1a), 0.08±0.02 nM (gt2a), 0.15±0.06 nM (gt2b), 0.90±0.2 nM (gt3a)
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机酸及其衍生物 |
| 类(Class) | 羧酸及其衍生物 |
| 亚类(Subclass) | 氨基酸、肽和类似物 |
| 中间层级节点(Intermediate Tree Nodes) | 肽 |
| 直接上位类(Direct Parent) | 环肽 |
| 其他上位类(Alternative Parents) | N-酰基-α氨基酸及其衍生物 大环内酰胺类 α-氨基酸酰胺 喹喔啉类 吡咯烷酰胺 茴香醚 烷基芳基醚 吡嗪类 环丙烷羧酸及其衍生物 叔羧酸酰胺 磺酰基 有机磺酸及其衍生物 氨基甲酸酯 杂芳族化合物 仲羧酸酰胺 内酰胺类 氧环化合物 氮杂环化合物 卡宾型1,3-偶极化合物 有机两性离子 有机钾盐 有机氮化合物 羰基化合物 有机氧化物 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 芳基醚 - α-氨基酸酰胺 - α-氨基酸或其衍生物 - 茴香醚 - 芳香族杂多环化合物 - 氮杂环 - 苯基化合物 - 脲酸酯 - 碳酰胺型1,3-双极性化合物 - 羰基 - 羧酰胺基 - 环状α-肽 - 环丙烷羧酸或其衍生物 - 乙醚 - 杂芳香族化合物 - 烃衍生物 - 肟 - M-噻唑啉 - N-乙酰基-α-氨基酸或其衍生物 - 有机1,3-双极性化合物 - 有机碱金属盐 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机钾盐 - 有机盐 - 有机磺酸或其衍生物 - 有机双性离子 - 有机杂环化合物 - 有机氮化合物 - 有机氧化合物 - 有机磺酸或其衍生物 - 有机硫化合物 - 氧杂环 - 苯酚醚 - 吡嗪 - 吡咯烷 - 吡咯烷羧酸或其衍生物 - 吡咯烷-2-甲酰胺 - 喹噁唑啉 - 醛基 - 磺酰基 - 叔羧酸酰胺 |
| 描述(Description) | 该化合物属于环肽类有机化合物。这类化合物含有具有肽主链的环状结构单元。 |
| 外部描述符(External Descriptors) | 暂无 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|